MedTrace Logo

Treatment With Indapamide in Patients With Post-Surgical Hypoparathyroidism

NCT07034677 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-08-11

No results posted yet for this study

Summary

The aim of this study is to investigate the effect of daily treatment with Indapamide for 14 days on urinary calcium excretion in patients with post surgical hypoparathyroidisme.

Conditions

  • Hypoparathyroidism Post-surgical

Interventions

DRUG

Indapamide 1.5 MG SR

14 days treatment with indapamide 1.5 mg/day compared to placebo

DRUG

Placebo

14 days treatment with placebo

Sponsors & Collaborators

  • Lars Rejnmark

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-31
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07034677 on ClinicalTrials.gov